Dr David Churchman to represent the Clinical Outcomes team at the International Congress of Parkinson’s Disease and Movement Disorders, Nice, France, from the 22nd - 26th September 2019.
ISPOR Clinical Outcome Assessment Special Interest Group will be hosting a virtual roundtable meeting to examine ISPOR members’ opinions on developing guiding principles for the use of COAs in real world studies.
The generic Patient Reported Outcome (PRO) measure – the Oxford Participation and Activities Questionnaire (OxPAQ) has been further validated for use in three more common conditions.
Minimal Important Difference (MID) and Effect Sizes for the measure’s domains now available
Oxford University Innovation's Clinical Outcome team will be attending the annual PROMS research conference in Leeds, UK on the 13th June 2019.
Oxford University Innovation's Clinical Outcome team will be attending the annual ISPOR conference in New Orleans, LA from the 18th - 22nd May 2019.
The Clinical Outcomes team at Oxford University Innovation are very pleased to announce the availability of diabetes-specific preference-based measures that can be used to produce valuable health economic data.
The OxPAQ is now validated for use in Chronic obstructive pulmonary disease (COPD), Aneurysmal subarachnoid haemorrhage (AHS) and Valvular heart disease.
Clinical Outcomes will be promoting some new additions to their portfolio of diabetes outcome measures at ATTD in Berlin, Germany, 20th -23rd February!
The Oxford Cognitive Screen, a stroke-specific screening test, is now available in Danish and an alternative to the MoCA.
